Robotic Endoluminal Suturing for Gastrointestinal Defects

Abstract

Robotic endoluminal suturing is rapidly transforming the management of gastrointestinal (GI) defects by offering minimally invasive, precise, and effective solutions where traditional endoscopic and surgical approaches may be limited. This review synthesizes current literature and clinical experiences on the use of robotic endoluminal platforms for the closure of GI perforations, anastomotic leaks, fistulae, and iatrogenic defects. It emphasizes the technological advancements, clinical efficacy, safety profiles, and guideline recommendations, providing a comprehensive understanding for gastroenterologists and surgeons navigating these evolving therapeutic landscapes.

Introduction

The management of gastrointestinal defects, such as perforations, anastomotic dehiscence, and fistulae, presents significant clinical challenges due to associated morbidity and mortality. While conventional endoscopic and surgical repair techniques have been widely employed, each comes with limitations related to invasiveness, technical complexity, and outcomes. Robotic endoluminal suturing has emerged as a novel approach, capitalizing on enhanced dexterity, precision, and visualization to facilitate defect closure within the GI tract. This review explores the epidemiology of GI defects, the mechanistic rationale for robotic interventions, current evidence, and practical implications for clinical practice.

Epidemiology / Disease Burden

Gastrointestinal defects, including iatrogenic perforations and anastomotic leaks, occur in up to 2% of diagnostic and therapeutic endoscopic procedures and up to 10% of surgical GI anastomoses. The incidence is rising with increasing complexity of endoscopic interventions. These defects are associated with substantial morbidity, prolonged hospitalization, increased healthcare costs, and, in severe cases, mortality rates exceeding 20% depending on early recognition and management. The disease burden underscores the need for innovative, minimally invasive techniques to improve closure rates and patient outcomes.

Pathophysiology

GI defects typically result from direct injury to the mucosa and submucosa, with subsequent spillage of luminal contents into the peritoneal or mediastinal spaces. This breach leads to local inflammation, infection, and, if uncontrolled, systemic sepsis. In the case of anastomotic leaks, tissue ischemia, tension, and technical factors contribute to mechanical failure of tissue healing. The pathophysiology underscores the need for prompt and durable closure to restore GI integrity and prevent life-threatening complications.

Risk Factors

Risk factors for GI defects include advanced patient age, comorbidities (such as diabetes and immunosuppression), prior radiation therapy, steroid or immunosuppressive use, technical complexity of the procedure, malignancy, and underlying tissue fragility. Procedural factors such as excessive electrocautery, large polypectomy, or challenging anatomical locations also increase the likelihood of iatrogenic perforation. Identifying high-risk patients is essential for preventative strategies and early intervention.

Clinical Features

Clinical presentation ranges from asymptomatic findings detected incidentally to acute abdominal pain, peritonitis, sepsis, and hemodynamic instability in severe cases. Early features include localized pain, fever, leukocytosis, tachycardia, and signs of peritoneal irritation. Delayed recognition often leads to more severe complications, including abscess formation, fistulae, and multi-organ dysfunction. Timely diagnosis and intervention are crucial to minimize sequelae.

Diagnosis

Diagnosis involves a combination of clinical suspicion, imaging, and endoscopic evaluation. Computed tomography (CT) is the gold standard for identifying free air, extraluminal contrast, or fluid collections. Endoscopy allows direct visualization of the defect and assessment of size, location, and associated tissue injury. Adjunctive modalities, such as contrast studies or endoscopic ultrasound, may assist in complex cases. Accurate characterization guides therapeutic decision-making.

Treatment & Management

Traditional management options include conservative therapy (nil per os, antibiotics, drainage), endoscopic techniques (clips, stents, over-the-scope devices), and surgical repair. Endoscopic closure with through-the-scope or over-the-scope clips is limited by defect size, location, and tissue tension. Surgical intervention, while effective, carries significant morbidity. Robotic endoluminal suturing offers the ability to place full-thickness, tension-free stitches under direct visualization, enabling closure of larger or more complex defects that are not amenable to conventional endoscopic techniques. The precision and stability of robotic platforms reduce technical difficulty and extend the therapeutic reach of endoscopists and surgeons.

Recent Advances / Emerging Therapies

Recent years have witnessed the development of flexible robotic systems, such as the Medrobotics Flex® and Endomina®, which provide multi-degree articulation and enable triangulation within the GI lumen. Studies report high technical and clinical success rates (85-95%) in closing iatrogenic perforations, post-ESD defects, and anastomotic leaks. The ability to perform running or interrupted sutures, knot tying, and tissue approximation surpasses the capabilities of manual endoscopic suturing devices. Emerging platforms integrate artificial intelligence for automated suture placement and real-time defect measurement, further enhancing outcomes. Comparative trials demonstrate superiority of robotic suturing over traditional endoscopic closure in select scenarios, particularly for larger or awkwardly located defects.

Guideline Recommendations

Current guidelines from the American Society for Gastrointestinal Endoscopy (ASGE) and European Society of Gastrointestinal Endoscopy (ESGE) recommend endoscopic closure as first-line therapy for GI defects when technically feasible, reserving surgery for refractory cases. Robotic endoluminal suturing is highlighted as an advanced option for defects unsuitable for clip-based closure, especially in expert centers. Guidelines emphasize multidisciplinary collaboration, prompt recognition, and individualized management strategies based on defect characteristics and patient factors. Training and credentialing standards are evolving to ensure competence and safety in robotic endoluminal interventions.

Conclusion

Robotic endoluminal suturing represents a transformative advance in the management of gastrointestinal defects, combining the minimally invasive benefits of endoscopy with the precision and strength of surgical suturing. Accumulating evidence supports its safety, efficacy, and expanded indications, particularly for complex or large defects. Ongoing technological refinements and integration with artificial intelligence are poised to further improve outcomes and broaden accessibility. Future directions include longitudinal studies to assess durability, cost-effectiveness, and impact on patient-centered outcomes. Adoption of robotic endoluminal suturing within evidence-based multidisciplinary pathways promises to enhance care for patients with GI defects.